OS Therapies Inc (OSTX)
OS Therapies Inc (NYSE-OSTX) is a healthcare company in the biotechnology industry whose common stock is listed on the New York Stock Exchange. The security context is common equity, meaning it represents an ownership interest in the company rather than a fund, note, or other instrument. Public descriptions indicate that the business works in biopharmaceutical research and development, with a focus on treatments for cancer-related conditions. Its efforts are centered on therapeutic programs for serious oncology indications, including rare and solid-tumor settings. This overview describes the listed common stock and its sector classification without making claims about performance, valuation, or investment merits.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-OSTX
|
$1.41
|
-9.2% Downside
|
Fair
|
$8.92
|
475.4% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
-2.0x
|
-6.5x
|
—
|
67.253 M
|
71.421 M
|
1.9%
|
81.3%
|
-258.3
|
—
|
43.5%
|
